Clinical Study of Cord Blood-derived IL-10/IL-15 CD19-CAR NK in the Treatment of Refractory/Relapsed B-cell NHL

Clinical trial NCT06707259 · RECRUITING

Trial details

NCT number

NCT06707259

Sponsor

Second Affiliated Hospital, Zhejiang University, School of Medicine

Status

RECRUITING

Phase

Phase 1

Study type

INTERVENTIONAL

Start date

2024-12-01

Primary completion

2026-12-01

Enrollment

24

View on ClinicalTrials.gov